男性饮酒与生育力:丹麦与北美前瞻性队列研究
该研究基于丹麦SnartForaeldre(662对夫妇)和北美PRESTO(2017对夫妇)两个前瞻性孕前队列,分析男性饮酒量与生育力(fecundability)的关联。汇总分析未发现男性饮酒与生育力下降的明确关联,但丹麦队列中每周饮酒≥6标准杯与生育力下降存在微弱关联。
要点
- 汇总分析中,男性饮酒量与生育力无显著关联。
- 丹麦队列中每周饮酒≥6标准杯与生育力下降呈弱关联。
- 两队列高饮酒量(6-13和≥14标准杯/周)结果不一致。
核心结论
- 汇总丹麦和北美前瞻性孕前队列数据,未发现男性饮酒与生育力下降的明确关联。
- 丹麦队列数据可能提示每周饮酒≥6标准杯与生育力下降存在弱关联,但两队列高饮酒量结果不一致。
研究设计与样本
- 前瞻性孕前队列研究,数据来自丹麦SnartForaeldre(SF)研究(662对夫妇)和北美Pregnancy Study Online(PRESTO)(2017对夫妇)。
- 参与者入组时间:SF为2011年8月至2019年6月,PRESTO为2013年6月至2019年6月。
- 分析限于入组时尝试怀孕≤6个周期的夫妇,随访至自报妊娠或12个月经周期。
主要发现
- 随访12个周期内累积妊娠比例为64.5%(1727对夫妇)。
- SF和PRESTO队列男性总饮酒量中位数(四分位距)分别为4.5(2.0-7.8)和4.1(1.0-8.6)标准杯/周。
- 汇总分析中,与不饮酒相比,每周饮酒1-5、6-13和≥14标准杯的调整生育力比值比(FR)分别为1.02(95%CI 0.90-1.17)、1.10(95%CI 0.96-1.27)和0.98(95%CI 0.81-1.18)。
- SF队列中,每周饮酒1-5、6-13和≥14标准杯的调整FR分别为0.97(95%CI 0.73-1.28)、0.81(95%CI 0.60-1.10)和0.82(95%CI 0.51-1.30)。
- PRESTO队列中,每周饮酒1-5、6-13和≥14标准杯的调整FR分别为1.02(95%CI 0.88-1.18)、1.20(95%CI 1.03-1.40)和1.03(95%CI 0.84-1.26)。
临床怎么用
- 基于当前证据,男性饮酒与生育力下降的关联不明确,但丹麦队列提示每周≥6标准杯可能存在弱关联。
- 临床咨询时可告知男性适量饮酒与生育力下降无明确关联,但高饮酒量(≥6标准杯/周)的潜在影响需结合个体情况考虑。
局限性
- 男性饮酒量仅在基线评估,未区分规律饮酒与暴饮。
- 未能分析特定类型酒精饮料的影响。
- 不能排除未测量因素(如饮食、心理健康)的残余混杂。
- 未考虑可能影响生殖的合并症(如癌症、代谢综合征),但该年龄组癌症和糖尿病患病率低。
- 最高饮酒类别(6-13和≥14标准杯/周)的结果在两个队列间不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does male alcohol consumption affect fecundability? SUMMARY ANSWER: In data pooled across Danish and North American preconception cohort studies, we found little evidence of an association between male alcohol consumption and reduced fecundability. WHAT IS KNOWN ALREADY: Experimental and clinical studies have shown that alcohol affects male reproductive physiology, mainly by altering male reproductive hormones and spermatogenesis. However, few epidemiologic studies have examined the association between alcohol consumption and male fertility. STUDY DESIGN, SIZE, DURATION: Data were collected from two ongoing prospective preconception cohort studies: the Danish 'SnartForaeldre' (SF) study (662 couples) and the North American 'Pregnancy Study Online' (PRESTO) (2017 couples). Participants included in the current analysis were enrolled from August 2011 through June 2019 (SF) and from June 2013 through June 2019 (PRESTO). PARTICIPANTS/MATERIALS, SETTING, METHODS: Eligible men were aged ≥18 years in SF and ≥21 years in PRESTO, in a stable relationship with a female partner and not using contraception or receiving fertility treatment. In both cohorts, alcohol consumption/serving size was self-reported as number of beers (330 mL/12 oz.), glasses of white or red wine (120 mL/4 oz. each), dessert wine (50 mL/2 oz.) and spirits (20 mL/1.5 oz.). Overall alcohol consumption was categorized as none, 1-5, 6-13 and ≥14 standard servings per week. Total menstrual cycles at risk were calculated using data from female partners' follow-up questionnaires, which were completed every 8 weeks until self-reported pregnancy or 12 menstrual cycles, whichever came first. Analyses were restricted to couples that had been trying to conceive for ≤6 cycles at study entry. Proportional probability regression models were used to compute fecundability ratios (FRs) and 95% confidence interval (CIs). We adjusted for male and female age, female partner's alcohol consumption, intercourse frequency, previous history of fathering a child, race/ethnicity, education, BMI, smoking and consumption of sugar-sweetened beverages and caffeine. MAIN RESULTS AND THE ROLE OF CHANCE: The cumulative proportion of couples who conceived during 12 cycles of follow-up were 1727 (64.5%). The median (interquartile range) of total male alcohol consumption was 4.5 (2.0-7.8) and 4.1 (1.0-8.6) standard servings per week in the SF and PRESTO cohorts, respectively. In pooled analyses, adjusted FRs for male alcohol consumption of 1-5, 6-13 and ≥14 standard servings per week compared with no alcohol consumption were 1.02 (95% CI: 0.90-1.17), 1.10 (95% CI: 0.96-1.27) and 0.98 (95% CI: 0.81-1.18), respectively. For SF, adjusted FRs of 1-5, 6-13 and ≥14 standard servings per week compared with no alcohol consumption were 0.97 (95% CI: 0.73-1.28), 0.81 (95% CI: 0.60-1.10) and 0.82 (95% CI: 0.51-1.30), respectively. For PRESTO, adjusted FRs of 1-5, 6-13 and ≥14 standard servings per week compared with no alcohol consumption were 1.02 (95% CI: 0.88-1.18), 1.20 (95% CI: 1.03-1.40) and 1.03 (95% CI: 0.84-1.26), respectively. LIMITATIONS, REASONS FOR CAUTION: Male alcohol consumption was ascertained at baseline only, and we did not distinguish between regular and binge drinking. In addition, we had insufficient numbers to study the effects of specific types of alcoholic beverages. As always, residual confounding by unmeasured factors, such as dietary factors and mental health, cannot be ruled out. Comorbidities thought to play a role in the reproductive setting (i.e. cancer, metabolic syndrome) were not considered in this study; however, the prevalence of cancer and diabetes was low in this age group. Findings for the highest categories of alcohol consumption (6-13 and ≥14 servings/week) were not consistent across the two cohorts. WIDER IMPLICATIONS OF THE FINDINGS: Despite little evidence of an association between male alcohol consumption and reduced fecundability in the pooled analysis, data from the Danish cohort might indicate a weak association between reduced fecundability and consumption of six or more servings per week. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Institutes of Health (R01-HD060680, R01-HD086742, R21-HD050264, R21-HD072326, R03-HD090315), the Novo Nordisk Foundation, Oticon Fonden, Politimester J.P.N. Colind og hustru Asmine Colinds mindelegat and Erna og Peter Houtveds studielegat. PRESTO receives in-kind donations from FertilityFriend.com, Kindara.com, Swiss Precision Diagnostics and Sandstone Diagnostics for the collection of data pertaining to fertility. Dr Wise serves as a consultant on uterine leiomyomata for AbbVie.com. All other authors declare no conflict of interest.
引用
- Høyer S, Riis AH, Toft G, et al. Male alcohol consumption and fecundability. Hum Reprod. 2020. PMID: 32155263. doi:10.1093/humrep/dez294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。